Adama Sacko
Overview
Explore the profile of Adama Sacko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahamar A, Vanheer L, Smit M, Sanogo K, Sinaba Y, Niambele S, et al.
Lancet Microbe
. 2024 Dec;
6(2):100966.
PMID: 39701119
Background: Triple artemisinin-based combination therapies (TACTs) can delay the spread of antimalarial drug resistance. Artesunate-amodiaquine is widely used for uncomplicated Plasmodium falciparum malaria. We therefore aimed to determine the safety...
2.
Mahamar A, Smit M, Sanogo K, Sinaba Y, Niambele S, Sacko A, et al.
Lancet Microbe
. 2024 May;
5(7):633-644.
PMID: 38705163
Background: Artemether-lumefantrine is widely used for uncomplicated Plasmodium falciparum malaria; sulfadoxine-pyrimethamine plus amodiaquine is used for seasonal malaria chemoprevention. We aimed to determine the efficacy of artemether-lumefantrine with and without...
3.
Oulton T, Mahamar A, Sanogo K, Diallo M, Youssouf A, Niambele S, et al.
Malar J
. 2022 Dec;
21(1):372.
PMID: 36474274
Background: In some settings, sensitive field diagnostic tools may be needed to achieve elimination of falciparum malaria. To this end, rapid diagnostic tests (RDTs) based on the detection of the...
4.
Ouologuem D, Dembele L, Dara A, Kone A, Diallo N, Sangare C, et al.
Antimicrob Agents Chemother
. 2022 Nov;
66(12):e0100122.
PMID: 36321830
The discovery and development of transmission-blocking therapies challenge malaria elimination and necessitate standard and reproducible bioassays to measure the blocking properties of antimalarial drugs and candidate compounds. Most of the...
5.
Stone W, Mahamar A, Smit M, Sanogo K, Sinaba Y, Niambele S, et al.
Lancet Microbe
. 2022 May;
3(5):e336-e347.
PMID: 35544095
Background: Tafenoquine was recently approved as a prophylaxis and radical cure for Plasmodium vivax infection, but its Plasmodium falciparum transmission-blocking efficacy is unclear. We aimed to establish the efficacy and...
6.
Stone W, Mahamar A, Sanogo K, Sinaba Y, Niambele S, Sacko A, et al.
Lancet Microbe
. 2022 Jan;
3(1):e41-e51.
PMID: 35028628
Background: Pyronaridine-artesunate is the most recently licensed artemisinin-based combination therapy. WHO has recommended that a single low dose of primaquine could be added to artemisinin-based combination therapies to reduce transmission...
7.
Talman A, Ouologuem D, Love K, Howick V, Mulamba C, Haidara A, et al.
Front Microbiol
. 2020 Mar;
11:246.
PMID: 32194521
remains one of the leading causes of child mortality, and nearly half of the world's population is at risk of contracting malaria. While pathogenesis results from replication of asexual forms...
8.
Coulibaly M, Gabriel E, Sinaba Y, Sylla D, Sacko A, Sylla L, et al.
Am J Trop Med Hyg
. 2017 Jul;
97(3):719-725.
PMID: 28722588
Malaria transmission-blocking vaccines (TBV) have been evaluated in field trials in Mali since 2013. However, the assays currently used to measure serum antibody TB activity (TBA) after vaccination are highly...
9.
Ursu R, Taillibert S, Banissi C, Vicaut E, Bailon O, Le Rhun E, et al.
Cancer Sci
. 2015 Jun;
106(9):1212-8.
PMID: 26094710
TLR-9 agonists are immunostimulating agents that have antitumor effects in animal models. A phase I trial was conducted to define the safety profile of subcutaneous injections, combined with intrathecally administration...
10.
Sacko A, Hou M, Temgoua M, Alkhafaji A, Marantidou A, Belin C, et al.
J Neurooncol
. 2015 Feb;
122(3):567-73.
PMID: 25700836
Functional independence in glioblastoma (GBM) patients is a key factor in measuring the quality of life. Progression free survival (PFS) and overall survival (OS) have been largely described. However, the...